Ultrasonographic Analysis of Trapezius Muscle for Efficient Botulinum Toxin Type A Injection

Background Patients nowadays seek medical reduction of the upper trapezius muscle to achieve aesthetic pleasing necklines Botulinum toxin type A (BoNT-A), a neurotoxin that reduces the force of muscle contraction, is widely used for shoulder contouring. However, detailed metrical data are lacking to guide clinical injection. Methods Forty healthy young women were enrolled. All subjects were seated for point marking and measuring of trapezius muscle (TM) anatomical data. At marked locations, the thickness of the subcutaneous tissue, the thickness of the TM, the TM's anterior border, and the depth from the skin surface to the middle of TM were measured using a real-time ultrasound scanner. In addition, photos were taken to assess the shoulder area proportion and shoulder angle. Results The shoulder area size among participants was 90 +/- 15.2 cm(2), the average area proportion was 0.55 +/- 0.1, and the shoulder angle was 23.12 degrees +/- 2.9 degrees. Ultrasonography data reveal that the thickness of the subcutaneous tissue, the thickness of the TM, and the depth from the skin surface to the middle of TM all thickened from the anterior line to the posterior line (P < 0.001). The length of the TM extending forward was 1.47 +/- 0.4 cm (range 0.51-1.31 cm). To better evaluate the appearance of the trapezius muscle, we constructed a grading system correlated to shoulder angle. Conclusion In this study, ultrasonography and photos were applied to assess the TM's anatomical features. Trapezius hypertrophy was described on a scale from 0 to 2 based on the shoulder angle. The findings of the present study provide a practical clinical guidance for precise and efficient BoNT-A administration.

Automated summary

This study utilized ultrasound and photos to assess the anatomical features of the upper trapezius muscle (TM) and constructed a grading system for trapezius hypertrophy based on shoulder angle. The findings provide practical clinical guidance for precise and efficient administration of BoNT-A.